目的:探讨基于德尔菲法的介入护理在静脉血栓滤器植入患者中的应用效果。方法:将60例行静脉血栓滤器植入术的下肢深静脉血栓形成(DVT)患者按照其意愿分为对照组21例和观察组39例,对照组采取常规围术期护理,观察组采用基于德尔菲法的介...目的:探讨基于德尔菲法的介入护理在静脉血栓滤器植入患者中的应用效果。方法:将60例行静脉血栓滤器植入术的下肢深静脉血栓形成(DVT)患者按照其意愿分为对照组21例和观察组39例,对照组采取常规围术期护理,观察组采用基于德尔菲法的介入护理策略,观察两组患者干预2周后静脉再通情况、康复效果、抑郁、焦虑情况。结果:观察组患者完全再通人数所占比例明显高于对照组( P<0.05);观察组患者患肢平面周径好转时间、皮肤色泽好转时间、住院时间均较对照组缩短,肺栓塞发生率明显低于对照组(P <0.05);观察组抑郁自评量表(SDS)及焦虑自评量表(SAS)评分明显低于对照组( P <0.05)。结论:基于德尔菲法建立的静脉血栓滤器植入介入护理能够有效提高患者血栓完全再通率,改善康复效果,缓解患者抑郁、焦虑情绪。展开更多
Background The objective of this study was to assess the clinical safety and efficacy of vena cava filter （VCF） placement, with particular emphasis on the incidence and risk factors of inferior vena cava thrombosis ...Background The objective of this study was to assess the clinical safety and efficacy of vena cava filter （VCF） placement, with particular emphasis on the incidence and risk factors of inferior vena cava thrombosis （VCT） after VCF placement. Methods Clinical data of patients with venous thromboembolism （VTE）, with or without placement of VCF, were analyzed in a retrospective single-center audit of medical records from January 2005 to June 2009. The collected data included demographics, procedural details, filter type, indications, and complications. Results A total of 168 cases of VTE （82 with VCF; 86 without VCF） were examined. Over a median follow-up of 24.2 months, VCT occurred in 18 of 82 patients with VCFs （11 males, 7 females, mean age 55.4 years）. In 86 patients without VCFs, VCT occurred in only 6 individuals （4 males, 2 females） during the study period. VCT was observed more frequently in patients fitted with VCFs than in those without VCFs （22% vs. 7.0%）. Conclusions The incidence of VCT in patients with VTE after VCF implantation was 22% approximately. Anticoagulation therapy should be continued for all patients with VCF placement, unless there is a specific contraindication. Almost all instances of VCT in patients with VCF implants in our study occurred after stopping anticoagulation treatment. The use of VCFs is increasing, and more trials are needed to confirm their benefit and accurately assess their safety.展开更多
文摘目的:探讨基于德尔菲法的介入护理在静脉血栓滤器植入患者中的应用效果。方法:将60例行静脉血栓滤器植入术的下肢深静脉血栓形成(DVT)患者按照其意愿分为对照组21例和观察组39例,对照组采取常规围术期护理,观察组采用基于德尔菲法的介入护理策略,观察两组患者干预2周后静脉再通情况、康复效果、抑郁、焦虑情况。结果:观察组患者完全再通人数所占比例明显高于对照组( P<0.05);观察组患者患肢平面周径好转时间、皮肤色泽好转时间、住院时间均较对照组缩短,肺栓塞发生率明显低于对照组(P <0.05);观察组抑郁自评量表(SDS)及焦虑自评量表(SAS)评分明显低于对照组( P <0.05)。结论:基于德尔菲法建立的静脉血栓滤器植入介入护理能够有效提高患者血栓完全再通率,改善康复效果,缓解患者抑郁、焦虑情绪。
文摘Background The objective of this study was to assess the clinical safety and efficacy of vena cava filter （VCF） placement, with particular emphasis on the incidence and risk factors of inferior vena cava thrombosis （VCT） after VCF placement. Methods Clinical data of patients with venous thromboembolism （VTE）, with or without placement of VCF, were analyzed in a retrospective single-center audit of medical records from January 2005 to June 2009. The collected data included demographics, procedural details, filter type, indications, and complications. Results A total of 168 cases of VTE （82 with VCF; 86 without VCF） were examined. Over a median follow-up of 24.2 months, VCT occurred in 18 of 82 patients with VCFs （11 males, 7 females, mean age 55.4 years）. In 86 patients without VCFs, VCT occurred in only 6 individuals （4 males, 2 females） during the study period. VCT was observed more frequently in patients fitted with VCFs than in those without VCFs （22% vs. 7.0%）. Conclusions The incidence of VCT in patients with VTE after VCF implantation was 22% approximately. Anticoagulation therapy should be continued for all patients with VCF placement, unless there is a specific contraindication. Almost all instances of VCT in patients with VCF implants in our study occurred after stopping anticoagulation treatment. The use of VCFs is increasing, and more trials are needed to confirm their benefit and accurately assess their safety.
